PHARMAFLOR: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHARMAFLOR
Largest movements
- Cash +€105,090
up €105,090 (+34.5%), from €304,200 to €409,290
mainly Net result for the year (+€129,524) and Other debts (+€35,219)
- Stocks and contracts +€18,148
up €18,148 (+7.8%), from €233,733 to €251,880
- Reserves +€129,520
up €129,520 (+113.8%), from €113,850 to €243,370
- Debts after one year -€36,000
down €36,000 (-9.8%), from €367,000 to €331,000
- Other debts +€35,219
up €35,219 (+272.2%), from €12,940 to €48,160
- Trade debts -€17,569
down €17,569 (-15.7%), from €112,069 to €94,499
- Tax, wage and social debts +€16,854
up €16,854 (+38.7%), from €43,555 to €60,409
of which Taxes: +€19,470
- Staff costs -€31,522
down €31,522 (-12.5%), from €253,080 to €221,557
- Gross operating margin +€31,462
up €31,462 (+8.1%), from €389,516 to €420,978
- Taxes +€19,542
up €19,542 (+53.9%), from €36,275 to €55,817
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €703,438 | €831,466 | +€128,028 | +18.2% |
| Fixed assets | 21/28 | €20,148 | €13,732 | -€6,416 | -31.8% |
| Tangible fixed assets | 22/27 | €20,028 | €13,612 | -€6,416 | -32.0% |
| Plant, machinery and equipment | 23 | €13,431 | €9,601 | -€3,830 | -28.5% |
| Furniture and vehicles | 24 | €6,597 | €4,011 | -€2,586 | -39.2% |
| Financial fixed assets | 28 | €120 | €120 | = | 0.0% |
| Current assets | 29/58 | €683,289 | €817,733 | +€134,444 | +19.7% |
| Stocks and contracts in progress | 3 | €233,733 | €251,880 | +€18,148 | +7.8% |
| Stocks | 30/36 | €233,733 | €251,880 | +€18,148 | +7.8% |
| Amounts receivable within one year | 40/41 | €142,001 | €150,191 | +€8,191 | +5.8% |
| Trade receivables | 40 | €137,380 | €148,842 | +€11,462 | +8.3% |
| Other amounts receivable | 41 | €4,621 | €1,349 | -€3,272 | -70.8% |
| Cash at bank and in hand | 54/58 | €304,200 | €409,290 | +€105,090 | +34.5% |
| Deferred charges and accrued income | 490/1 | €3,356 | €6,371 | +€3,015 | +89.9% |
| Total equity and liabilities | 10/49 | €703,438 | €831,466 | +€128,028 | +18.2% |
| Equity | 10/15 | €163,864 | €293,388 | +€129,524 | +79.0% |
| Contributions | 10/11 | €50,000 | €50,000 | = | 0.0% |
| Reserves | 13 | €113,850 | €243,370 | +€129,520 | +113.8% |
| Distributable reserves | 133 | €113,850 | €243,370 | +€129,520 | +113.8% |
| Profit (loss) carried forward | 14 | €14 | €18 | +€4 | +28.4% |
| Amounts payable | 17/49 | €539,574 | €538,078 | -€1,496 | -0.3% |
| Amounts payable after more than one year | 17 | €367,000 | €331,000 | -€36,000 | -9.8% |
| Other amounts payable | 178/9 | €367,000 | €331,000 | -€36,000 | -9.8% |
| Amounts payable within one year | 42/48 | €168,564 | €203,068 | +€34,504 | +20.5% |
| Trade debts | 44 | €112,069 | €94,499 | -€17,569 | -15.7% |
| Suppliers | 440/4 | €112,069 | €94,499 | -€17,569 | -15.7% |
| Taxes, remuneration and social security | 45 | €43,555 | €60,409 | +€16,854 | +38.7% |
| Taxes | 450/3 | €4,553 | €24,023 | +€19,470 | +427.6% |
| Remuneration and social security | 454/9 | €39,001 | €36,386 | -€2,615 | -6.7% |
| Other amounts payable | 47/48 | €12,940 | €48,160 | +€35,219 | +272.2% |
| Accrued charges and deferred income | 492/3 | €4,010 | €4,010 | = | 0.0% |
| Remuneration, social security and pensions | 62 | €253,080 | €221,557 | -€31,522 | -12.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €6,337 | €6,416 | +€79 | +1.3% |
| Other operating charges | 640/8 | €2,015 | €2,036 | +€21 | +1.0% |
| Gross operating margin | 9900 | €389,516 | €420,978 | +€31,462 | +8.1% |
| Operating profit (loss) | 9901 | €128,085 | €190,969 | +€62,884 | +49.1% |
| Financial income | 75/76B | €455 | €37 | -€418 | -91.8% |
| Recurring financial income | 75 | €455 | €37 | -€418 | -91.8% |
| Financial charges | 65/66B | €4,991 | €5,666 | +€674 | +13.5% |
| Recurring financial charges | 65 | €4,991 | €5,666 | +€674 | +13.5% |
| Profit (loss) for the period before taxes | 9903 | €123,549 | €185,341 | +€61,792 | +50.0% |
| Income taxes | 67/77 | €36,275 | €55,817 | +€19,542 | +53.9% |
| Profit (loss) for the period | 9904 | €87,274 | €129,524 | +€42,250 | +48.4% |
| Profit (loss) for the period to be appropriated | 9905 | €87,274 | €129,524 | +€42,250 | +48.4% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 7 October 2026 via checked.be.